I find it hard to believe they cancelled the call 2 weeks ago from today because the board wanted to terminate NP, and then sat on the news for 2 weeks due. I highly suspect NP was sitting in the way of a potential deal, and removing him as the CEO and Kelly as the COB was a precondition to a deal. Any potential partner that's willing to put down a significant initial payment and obligate the company to a long-term commitment is going to insure CytoDyn's management can meet their milestones, and unfortunately current management's record wasn't good. If so, I'm not expecting any PRs until the deal is inked. But, as you said, this is all speculation.

Quote:

---

A partnership/BO suitor may have conditioned any potential deal on Nader's removal. Perhaps he was at loggerheads with the rest of the Board over the path forward. It could also be many other things. We should learn more over time, but I see little value in pure guesswork at this time.

I'm struggling to grasp why this termination took almost 2 weeks to finalize. I would like to think that other matters have also been in play.

---